New “Compromise” on IP Waiver for Covid Vaccines Is Worse Than No Deal, Activists Say

March 16, 2022 |
Covid Pill Prescriber Rules Limit Reach of ‘Test to Treat’ Plan
Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...